 Drug Delivery Devices Market Insights, Competitive Landscape, and Market Forecast - 2033
The global drug delivery devices market is undergoing steady expansion as healthcare delivery models increasingly emphasize precision, safety, and patient convenience. The market is valued at 499.1... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global drug delivery devices market is undergoing steady expansion as healthcare delivery models increasingly emphasize precision, safety, and patient convenience. The market is valued at 499.1 bn in 2026 and is projected to reach 843.7 bn by 2033, registering a CAGR of 7.80% over the forecast period. Drug delivery devices are essential components in modern therapeutics, enabling controlled administration of medications while improving treatment adherence. The rising incidence of chronic diseases such as diabetes, cancer, and autoimmune disorders continues to elevate demand for efficient and user-friendly delivery systems. In parallel, technological innovation and integration of smart features are transforming traditional delivery methods into advanced, connected solutions. As healthcare shifts toward decentralized and home-based care, the role of reliable drug delivery devices becomes increasingly critical in ensuring consistent and effective treatment outcomes.Market Insights The drug delivery devices market encompasses a wide spectrum of technologies, including injectables, transdermal systems, implantable devices, and inhalation-based delivery solutions. The industry is witnessing a transition toward minimally invasive and patient-friendly technologies, with a strong focus on ease of use and accuracy. Innovations such as wearable injectors and smart insulin pens are gaining traction, supported by the growing demand for self-administration. Pharmaceutical companies are actively collaborating with device manufacturers to create combination products that integrate drugs with advanced delivery mechanisms. The increasing prominence of biologics and biosimilars is further driving the need for specialized delivery platforms capable of handling complex formulations. Digital health integration is another key trend, enabling remote monitoring and adherence tracking. These developments are collectively enhancing patient engagement while improving therapeutic efficiency across multiple treatment areas. Drivers The expansion of the drug delivery devices market is largely driven by the growing global burden of chronic illnesses that require long-term medication management. Diabetes, cardiovascular diseases, and autoimmune conditions necessitate regular drug administration, increasing reliance on advanced delivery systems. The aging population is another major contributor, as elderly individuals often require continuous therapeutic support. Technological advancements have significantly improved device functionality, with innovations such as needle-free injectors and automated systems enhancing patient comfort and compliance. Rising awareness about modern treatment options and increasing healthcare accessibility in developing regions are also supporting market growth. Additionally, the shift toward minimally invasive procedures is encouraging the adoption of innovative delivery methods that reduce discomfort and improve patient experience. Business Opportunity The market presents considerable opportunities for growth, particularly in the development of personalized and connected drug delivery solutions. As precision medicine gains momentum, there is a growing need for devices that can be tailored to individual patient requirements. Companies investing in digital integration and smart technologies can capitalize on the increasing demand for real-time monitoring and data-driven healthcare solutions. Emerging economies offer significant growth potential due to improving healthcare infrastructure and rising disposable incomes. The expansion of biologic therapies is also creating opportunities for advanced delivery systems designed to handle complex drug compositions. Strategic partnerships between pharmaceutical companies and technology firms are expected to accelerate innovation and product commercialization. Furthermore, the increasing preference for home healthcare is driving demand for portable, easy-to-use devices that enable patients to manage treatments independently. Region Analysis North America holds a dominant position in the drug delivery devices market, supported by a well-established healthcare infrastructure, high adoption of advanced technologies, and strong presence of leading industry players. The region benefits from continuous research and development activities and favorable regulatory policies that encourage innovation. Europe represents another significant market, driven by increasing healthcare investments and growing demand for advanced therapeutic solutions. The Asia Pacific region is anticipated to experience the fastest growth, fueled by a large patient population, rapid urbanization, and improving access to healthcare services. Countries such as China and India are emerging as key contributors due to expanding pharmaceutical manufacturing capabilities and supportive government initiatives. Latin America and the Middle East & Africa are also witnessing steady growth, supported by improving healthcare systems and rising awareness about advanced medical technologies. Key Players • Eli Lilly and Company • Becton Dickinson And Co. • Novo Nordisk • Sanofi • Johnson & Johnson • Roche • Pfizer • AbbVie • Mylan N.V. (Viatris) • Insulet corporation • Medtronic Plc Segmentation By Product: • Self-Injector o Single Chamber Self Injector o Dual Chamber Self Injector • Needle Free Injectors o Pre-Filled Needle Free Injectors o Fill-Able Needle Free Injectors • Auto-Injectors o Pre-Filled Auto-Injector o Fill-Able Auto-Injector • Wearable Injectors o Wearable Patch Injectors o Off-body Worn Injectors • Insulin Pens o Reusable Insulin Pens o Disposable Insulin Pens o Smart Insulin Pens • Implantable Drug Delivery o Contraceptive Implants o Intravitreal Implants o Buprenorphine Subdermal Implant o Implantable Infusion Pumps • Transdermal Patches o Drug in Adhesive Patches o Matrix Patches o Microneedle Patches o Reservoir Patches By Usage: • Disposable Devices • Reusable Devices By Route of Administration: • Transdermal • Subcutaneous • Intramuscular • Implantable By Sales Channel: • Hospitals • Specialty Clinics • Retail Pharmacy Chains • Drug Stores • Online Sales Channel By Application: • Diabetes • Anaphylaxis • Rheumatoid Arthritis • Cancer • Hormonal Therapy • Ophthalmology • Others By Geographic Coverage: • North America • Latin America • Europe • Asia Pacific • Middle East & Africa Table of Contents1. Executive Summary1.1. Global Drug Delivery Devices Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2026 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. COVID-19 Impact Analysis 2.5. Porter's Five Forces Analysis 2.6. Impact of Russia-Ukraine Conflict 2.7. PESTLE Analysis 2.8. Regulatory Analysis 2.9. Price Trend Analysis 2.9.1. Current Prices and Future Projections, 2025-2033 2.9.2. Price Impact Factors 3. Global Drug Delivery Devices Market Outlook, 2020-2033 3.1. Global Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn), 2020-2033 3.1.1. Self-Injector 3.1.1.1. Single Chamber Self Injector 3.1.1.2. Dual Chamber Self Injector 3.1.2. Needle Free Injectors 3.1.2.1. Pre-Filled Needle Free Injectors 3.1.2.2. Fill-Able Needle Free Injectors 3.1.3. Auto-Injectors 3.1.3.1. Pre-Filled Auto-Injector 3.1.3.2. Fill-Able Auto-Injector 3.1.4. Wearable Injectors 3.1.4.1. Wearable Patch Injectors 3.1.4.2. Off-body Worn Injectors 3.1.5. Insulin Pens 3.1.6. Implantable Drug Delivery 3.1.7. Transdermal Patches 3.2. Global Drug Delivery Devices Market Outlook, by Usage, Value (US$ Bn), 2020-2033 3.2.1. Disposable Devices 3.2.2. Reusable Devices 3.3. Global Drug Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033 3.3.1. Transdermal 3.3.2. Subcutaneous 3.3.3. Intramuscular 3.3.4. Implantable 3.4. Global Drug Delivery Devices Market Outlook, by Sales Channel, Value (US$ Bn), 2020-2033 3.4.1. Hospitals 3.4.2. Specialty Clinics 3.4.3. Retail Pharmacy Chains 3.4.4. Drug Stores 3.4.5. Online Sales Channel 3.5. Global Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033 3.5.1. Diabetes 3.5.2. Anaphylaxis 3.5.3. Rheumatoid Arthritis 3.5.4. Cancer 3.5.5. Hormonal Therapy 3.5.6. Ophthalmology 3.5.7. Others 3.6. Global Drug Delivery Devices Market Outlook, by Region, Value (US$ Bn), 2020-2033 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Latin America 3.6.5. Middle East & Africa 4. North America Drug Delivery Devices Market Outlook, 2020-2033 4.1. North America Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn), 2020-2033 4.1.1. Self-Injector 4.1.1.1. Single Chamber Self Injector 4.1.1.2. Dual Chamber Self Injector 4.1.2. Needle Free Injectors 4.1.2.1. Pre-Filled Needle Free Injectors 4.1.2.2. Fill-Able Needle Free Injectors 4.1.3. Auto-Injectors 4.1.3.1. Pre-Filled Auto-Injector 4.1.3.2. Fill-Able Auto-Injector 4.1.4. Wearable Injectors 4.1.4.1. Wearable Patch Injectors 4.1.4.2. Off-body Worn Injectors 4.1.5. Insulin Pens 4.1.6. Implantable Drug Delivery 4.1.7. Transdermal Patches 4.2. North America Drug Delivery Devices Market Outlook, by Usage, Value (US$ Bn), 2020-2033 4.2.1. Disposable Devices 4.2.2. Reusable Devices 4.3. North America Drug Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033 4.3.1. Transdermal 4.3.2. Subcutaneous 4.3.3. Intramuscular 4.3.4. Implantable 4.4. North America Drug Delivery Devices Market Outlook, by Sales Channel, Value (US$ Bn), 2020-2033 4.4.1. Hospitals 4.4.2. Specialty Clinics 4.4.3. Retail Pharmacy Chains 4.4.4. Drug Stores 4.4.5. Online Sales Channel 4.5. North America Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033 4.5.1. Diabetes 4.5.2. Anaphylaxis 4.5.3. Rheumatoid Arthritis 4.5.4. Cancer 4.5.5. Hormonal Therapy 4.5.6. Ophthalmology 4.5.7. Others 4.6. North America Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033 4.6.1. U.S. Drug Delivery Devices Market Outlook, by Product, 2020-2033 4.6.2. U.S. Drug Delivery Devices Market Outlook, by Usage, 2020-2033 4.6.3. U.S. Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 4.6.4. U.S. Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 4.6.5. U.S. Drug Delivery Devices Market Outlook, by Application, 2020-2033 4.6.6. Canada Drug Delivery Devices Market Outlook, by Product, 2020-2033 4.6.7. Canada Drug Delivery Devices Market Outlook, by Usage, 2020-2033 4.6.8. Canada Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 4.6.9. Canada Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 4.6.10. Canada Drug Delivery Devices Market Outlook, by Application, 2020-2033 4.7. BPS Analysis/Market Attractiveness Analysis 5. Europe Drug Delivery Devices Market Outlook, 2020-2033 5.1. Europe Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn), 2020-2033 5.1.1. Self-Injector 5.1.1.1. Single Chamber Self Injector 5.1.1.2. Dual Chamber Self Injector 5.1.2. Needle Free Injectors 5.1.2.1. Pre-Filled Needle Free Injectors 5.1.2.2. Fill-Able Needle Free Injectors 5.1.3. Auto-Injectors 5.1.3.1. Pre-Filled Auto-Injector 5.1.3.2. Fill-Able Auto-Injector 5.1.4. Wearable Injectors 5.1.4.1. Wearable Patch Injectors 5.1.4.2. Off-body Worn Injectors 5.1.5. Insulin Pens 5.1.6. Implantable Drug Delivery 5.1.7. Transdermal Patches 5.2. Europe Drug Delivery Devices Market Outlook, by Usage, Value (US$ Bn), 2020-2033 5.2.1. Disposable Devices 5.2.2. Reusable Devices 5.3. Europe Drug Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033 5.3.1. Transdermal 5.3.2. Subcutaneous 5.3.3. Intramuscular 5.3.4. Implantable 5.4. Europe Drug Delivery Devices Market Outlook, by Sales Channel, Value (US$ Bn), 2020-2033 5.4.1. Hospitals 5.4.2. Specialty Clinics 5.4.3. Retail Pharmacy Chains 5.4.4. Drug Stores 5.4.5. Online Sales Channel 5.5. Europe Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033 5.5.1. Diabetes 5.5.2. Anaphylaxis 5.5.3. Rheumatoid Arthritis 5.5.4. Cancer 5.5.5. Hormonal Therapy 5.5.6. Ophthalmology 5.5.7. Others 5.6. Europe Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033 5.6.1. Germany Drug Delivery Devices Market Outlook, by Product, 2020-2033 5.6.2. Germany Drug Delivery Devices Market Outlook, by Usage, 2020-2033 5.6.3. Germany Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 5.6.4. Germany Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 5.6.5. Germany Drug Delivery Devices Market Outlook, by Application, 2020-2033 5.6.6. Italy Drug Delivery Devices Market Outlook, by Product, 2020-2033 5.6.7. Italy Drug Delivery Devices Market Outlook, by Usage, 2020-2033 5.6.8. Italy Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 5.6.9. Italy Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 5.6.10. Italy Drug Delivery Devices Market Outlook, by Application, 2020-2033 5.6.11. France Drug Delivery Devices Market Outlook, by Product, 2020-2033 5.6.12. France Drug Delivery Devices Market Outlook, by Usage, 2020-2033 5.6.13. France Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 5.6.14. France Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 5.6.15. France Drug Delivery Devices Market Outlook, by Application, 2020-2033 5.6.16. U.K. Drug Delivery Devices Market Outlook, by Product, 2020-2033 5.6.17. U.K. Drug Delivery Devices Market Outlook, by Usage, 2020-2033 5.6.18. U.K. Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 5.6.19. U.K. Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 5.6.20. U.K. Drug Delivery Devices Market Outlook, by Application, 2020-2033 5.6.21. Spain Drug Delivery Devices Market Outlook, by Product, 2020-2033 5.6.22. Spain Drug Delivery Devices Market Outlook, by Usage, 2020-2033 5.6.23. Spain Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 5.6.24. Spain Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 5.6.25. Spain Drug Delivery Devices Market Outlook, by Application, 2020-2033 5.6.26. Russia Drug Delivery Devices Market Outlook, by Product, 2020-2033 5.6.27. Russia Drug Delivery Devices Market Outlook, by Usage, 2020-2033 5.6.28. Russia Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 5.6.29. Russia Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 5.6.30. Russia Drug Delivery Devices Market Outlook, by Application, 2020-2033 5.6.31. Rest of Europe Drug Delivery Devices Market Outlook, by Product, 2020-2033 5.6.32. Rest of Europe Drug Delivery Devices Market Outlook, by Usage, 2020-2033 5.6.33. Rest of Europe Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 5.6.34. Rest of Europe Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 5.6.35. Rest of Europe Drug Delivery Devices Market Outlook, by Application, 2020-2033 5.7. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Drug Delivery Devices Market Outlook, 2020-2033 6.1. Asia Pacific Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn), 2020-2033 6.1.1. Self-Injector 6.1.1.1. Single Chamber Self Injector 6.1.1.2. Dual Chamber Self Injector 6.1.2. Needle Free Injectors 6.1.2.1. Pre-Filled Needle Free Injectors 6.1.2.2. Fill-Able Needle Free Injectors 6.1.3. Auto-Injectors 6.1.3.1. Pre-Filled Auto-Injector 6.1.3.2. Fill-Able Auto-Injector 6.1.4. Wearable Injectors 6.1.4.1. Wearable Patch Injectors 6.1.4.2. Off-body Worn Injectors 6.1.5. Insulin Pens 6.1.6. Implantable Drug Delivery 6.1.7. Transdermal Patches 6.2. Asia Pacific Drug Delivery Devices Market Outlook, by Usage, Value (US$ Bn), 2020-2033 6.2.1. Disposable Devices 6.2.2. Reusable Devices 6.3. Asia Pacific Drug Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033 6.3.1. Transdermal 6.3.2. Subcutaneous 6.3.3. Intramuscular 6.3.4. Implantable 6.4. Asia Pacific Drug Delivery Devices Market Outlook, by Sales Channel, Value (US$ Bn), 2020-2033 6.4.1. Hospitals 6.4.2. Specialty Clinics 6.4.3. Retail Pharmacy Chains 6.4.4. Drug Stores 6.4.5. Online Sales Channel 6.5. Asia Pacific Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033 6.5.1. Diabetes 6.5.2. Anaphylaxis 6.5.3. Rheumatoid Arthritis 6.5.4. Cancer 6.5.5. Hormonal Therapy 6.5.6. Ophthalmology 6.5.7. Others 6.6. Asia Pacific Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033 6.6.1. China Drug Delivery Devices Market Outlook, by Product, 2020-2033 6.6.2. China Drug Delivery Devices Market Outlook, by Usage, 2020-2033 6.6.3. China Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 6.6.4. China Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 6.6.5. China Drug Delivery Devices Market Outlook, by Application, 2020-2033 6.6.6. Japan Drug Delivery Devices Market Outlook, by Product, 2020-2033 6.6.7. Japan Drug Delivery Devices Market Outlook, by Usage, 2020-2033 6.6.8. Japan Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 6.6.9. Japan Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 6.6.10. Japan Drug Delivery Devices Market Outlook, by Application, 2020-2033 6.6.11. South Korea Drug Delivery Devices Market Outlook, by Product, 2020-2033 6.6.12. South Korea Drug Delivery Devices Market Outlook, by Usage, 2020-2033 6.6.13. South Korea Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 6.6.14. South Korea Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 6.6.15. South Korea Drug Delivery Devices Market Outlook, by Application, 2020-2033 6.6.16. India Drug Delivery Devices Market Outlook, by Product, 2020-2033 6.6.17. India Drug Delivery Devices Market Outlook, by Usage, 2020-2033 6.6.18. India Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 6.6.19. India Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 6.6.20. India Drug Delivery Devices Market Outlook, by Application, 2020-2033 6.6.21. Southeast Asia Drug Delivery Devices Market Outlook, by Product, 2020-2033 6.6.22. Southeast Asia Drug Delivery Devices Market Outlook, by Usage, 2020-2033 6.6.23. Southeast Asia Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 6.6.24. Southeast Asia Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 6.6.25. Southeast Asia Drug Delivery Devices Market Outlook, by Application, 2020-2033 6.6.26. Rest of SAO Drug Delivery Devices Market Outlook, by Product, 2020-2033 6.6.27. Rest of SAO Drug Delivery Devices Market Outlook, by Usage, 2020-2033 6.6.28. Rest of SAO Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 6.6.29. Rest of SAO Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 6.6.30. Rest of SAO Drug Delivery Devices Market Outlook, by Application, 2020-2033 6.7. BPS Analysis/Market Attractiveness Analysis 7. Latin America Drug Delivery Devices Market Outlook, 2020-2033 7.1. Latin America Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn), 2020-2033 7.1.1. Self-Injector 7.1.1.1. Single Chamber Self Injector 7.1.1.2. Dual Chamber Self Injector 7.1.2. Needle Free Injectors 7.1.2.1. Pre-Filled Needle Free Injectors 7.1.2.2. Fill-Able Needle Free Injectors 7.1.3. Auto-Injectors 7.1.3.1. Pre-Filled Auto-Injector 7.1.3.2. Fill-Able Auto-Injector 7.1.4. Wearable Injectors 7.1.4.1. Wearable Patch Injectors 7.1.4.2. Off-body Worn Injectors 7.1.5. Insulin Pens 7.1.6. Implantable Drug Delivery 7.1.7. Transdermal Patches 7.2. Latin America Drug Delivery Devices Market Outlook, by Usage, Value (US$ Bn), 2020-2033 7.2.1. Disposable Devices 7.2.2. Reusable Devices 7.3. Latin America Drug Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033 7.3.1. Transdermal 7.3.2. Subcutaneous 7.3.3. Intramuscular 7.3.4. Implantable 7.4. Latin America Drug Delivery Devices Market Outlook, by Sales Channel, Value (US$ Bn), 2020-2033 7.4.1. Hospitals 7.4.2. Specialty Clinics 7.4.3. Retail Pharmacy Chains 7.4.4. Drug Stores 7.4.5. Online Sales Channel 7.5. Latin America Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033 7.5.1. Diabetes 7.5.2. Anaphylaxis 7.5.3. Rheumatoid Arthritis 7.5.4. Cancer 7.5.5. Hormonal Therapy 7.5.6. Ophthalmology 7.5.7. Others 7.6. Latin America Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033 7.6.1. Brazil Drug Delivery Devices Market Outlook, by Product, 2020-2033 7.6.2. Brazil Drug Delivery Devices Market Outlook, by Usage, 2020-2033 7.6.3. Brazil Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 7.6.4. Brazil Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 7.6.5. Brazil Drug Delivery Devices Market Outlook, by Application, 2020-2033 7.6.6. Mexico Drug Delivery Devices Market Outlook, by Product, 2020-2033 7.6.7. Mexico Drug Delivery Devices Market Outlook, by Usage, 2020-2033 7.6.8. Mexico Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 7.6.9. Mexico Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 7.6.10. Mexico Drug Delivery Devices Market Outlook, by Application, 2020-2033 7.6.11. Argentina Drug Delivery Devices Market Outlook, by Product, 2020-2033 7.6.12. Argentina Drug Delivery Devices Market Outlook, by Usage, 2020-2033 7.6.13. Argentina Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 7.6.14. Argentina Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 7.6.15. Argentina Drug Delivery Devices Market Outlook, by Application, 2020-2033 7.6.16. Rest of LATAM Drug Delivery Devices Market Outlook, by Product, 2020-2033 7.6.17. Rest of LATAM Drug Delivery Devices Market Outlook, by Usage, 2020-2033 7.6.18. Rest of LATAM Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 7.6.19. Rest of LATAM Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 7.6.20. Rest of LATAM Drug Delivery Devices Market Outlook, by Application, 2020-2033 7.7. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Drug Delivery Devices Market Outlook, 2020-2033 8.1. Middle East & Africa Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn), 2020-2033 8.1.1. Self-Injector 8.1.1.1. Single Chamber Self Injector 8.1.1.2. Dual Chamber Self Injector 8.1.2. Needle Free Injectors 8.1.2.1. Pre-Filled Needle Free Injectors 8.1.2.2. Fill-Able Needle Free Injectors 8.1.3. Auto-Injectors 8.1.3.1. Pre-Filled Auto-Injector 8.1.3.2. Fill-Able Auto-Injector 8.1.4. Wearable Injectors 8.1.4.1. Wearable Patch Injectors 8.1.4.2. Off-body Worn Injectors 8.1.5. Insulin Pens 8.1.6. Implantable Drug Delivery 8.1.7. Transdermal Patches 8.2. Middle East & Africa Drug Delivery Devices Market Outlook, by Usage, Value (US$ Bn), 2020-2033 8.2.1. Disposable Devices 8.2.2. Reusable Devices 8.3. Middle East & Africa Drug Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033 8.3.1. Transdermal 8.3.2. Subcutaneous 8.3.3. Intramuscular 8.3.4. Implantable 8.4. Middle East & Africa Drug Delivery Devices Market Outlook, by Sales Channel, Value (US$ Bn), 2020-2033 8.4.1. Hospitals 8.4.2. Specialty Clinics 8.4.3. Retail Pharmacy Chains 8.4.4. Drug Stores 8.4.5. Online Sales Channel 8.5. Middle East & Africa Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033 8.5.1. Diabetes 8.5.2. Anaphylaxis 8.5.3. Rheumatoid Arthritis 8.5.4. Cancer 8.5.5. Hormonal Therapy 8.5.6. Ophthalmology 8.5.7. Others 8.6. Middle East & Africa Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033 8.6.1. GCC Drug Delivery Devices Market Outlook, by Product, 2020-2033 8.6.2. GCC Drug Delivery Devices Market Outlook, by Usage, 2020-2033 8.6.3. GCC Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 8.6.4. GCC Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 8.6.5. GCC Drug Delivery Devices Market Outlook, by Application, 2020-2033 8.6.6. South Africa Drug Delivery Devices Market Outlook, by Product, 2020-2033 8.6.7. South Africa Drug Delivery Devices Market Outlook, by Usage, 2020-2033 8.6.8. South Africa Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 8.6.9. South Africa Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 8.6.10. South Africa Drug Delivery Devices Market Outlook, by Application, 2020-2033 8.6.11. Egypt Drug Delivery Devices Market Outlook, by Product, 2020-2033 8.6.12. Egypt Drug Delivery Devices Market Outlook, by Usage, 2020-2033 8.6.13. Egypt Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 8.6.14. Egypt Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 8.6.15. Egypt Drug Delivery Devices Market Outlook, by Application, 2020-2033 8.6.16. Nigeria Drug Delivery Devices Market Outlook, by Product, 2020-2033 8.6.17. Nigeria Drug Delivery Devices Market Outlook, by Usage, 2020-2033 8.6.18. Nigeria Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 8.6.19. Nigeria Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 8.6.20. Nigeria Drug Delivery Devices Market Outlook, by Application, 2020-2033 8.6.21. Rest of Middle East Drug Delivery Devices Market Outlook, by Product, 2020-2033 8.6.22. Rest of Middle East Drug Delivery Devices Market Outlook, by Usage, 2020-2033 8.6.23. Rest of Middle East Drug Delivery Devices Market Outlook, by Route of Administration, 2020-2033 8.6.24. Rest of Middle East Drug Delivery Devices Market Outlook, by Sales Channel, 2020-2033 8.6.25. Rest of Middle East Drug Delivery Devices Market Outlook, by Application, 2020-2033 8.7. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Vs Segment Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. Eli Lilly and Company 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Developments 9.4.2. Becton Dickinson And Co. 9.4.3. Novo Nordisk 9.4.4. Sanofi 9.4.5. Johnson & Johnson 9.4.6. Roche 9.4.7. Pfizer 9.4.8. AbbVie 9.4.9. Mylan N.V. (Viatris) 9.4.10. Insulet corporation 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（食品）の最新刊レポート
Fairfield Market Research社の 食料・飲料分野 での最新刊レポート
本レポートと同じKEY WORD（drug）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
